Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Relmada Therapeutics is a clinical-stage biotechnology company focused on developing novel drugs for neurological, psychiatric, and cancer-related conditions. Its pipeline includes candidates targeting depression, Tourette Syndrome, bladder cancer, and neurosteroid-related disorders. The company leverages extensive intellectual property, strategic licensing, and acquisitions to address high unmet medical needs, aiming for long-term growth through innovative, differentiated therapies in large markets.
This description was generated via AI from an annual report. Updated about 1 year ago.